SABBY 13G BVXV 1.04.23

Company

Scinai Immunotherapeutics Ltd.

Filed

January 4, 2023

Accession Number

0001535610-23-000014

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →